Thrive Capital Management, LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1845943 FORT WASHINGTON, PA

Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$4,239,277

-$1,715 QoQ

Shares Held

7,824

+9.4% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

1.33%

of 13F equity value

Holder Rank

#267

of 870 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Thrive Capital Management, LLC holds $13,446,022 across 3 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (31.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	27,428	$4,622,715
2	ELAN	Elanco Animal Health Inc	186,267	$4,584,030
3	UTHR	UNITED THERAPEUTICS Corp This page	7,824	$4,239,277

All Filings in UTHR

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,239,277	7,824	+9.4%	Shares	Sole	2026-08-05
2026-03-31	$4,240,992	7,152	-2.2%	Shares	Sole	2026-04-27
2025-12-31	$3,562,284	7,311	—	Shares	Sole	2026-02-09
No filing history on record for this holder in this stock.